Clinical Trial News and Research

RSS
Aastrom Biosciences reports third quarter 2010 FY results

Aastrom Biosciences reports third quarter 2010 FY results

11 May 2010
CrystalGenomics completes European Phase I SAD study of CG400549 antibiotic candidate

CrystalGenomics completes European Phase I SAD study of CG400549 antibiotic candidate

11 May 2010
Harbor BioSciences reports encouraging results from Triolex Phase IIa trials

Harbor BioSciences reports encouraging results from Triolex Phase IIa trials

10 May 2010
Immunomedics third-quarter revenues increase to $10.7 million

Immunomedics third-quarter revenues increase to $10.7 million

10 May 2010
European patent strengthens Soligenix' topically active steroid intellectual property portfolio

European patent strengthens Soligenix' topically active steroid intellectual property portfolio

10 May 2010
Lexicon Pharmaceuticals first-quarter revenues down 61%

Lexicon Pharmaceuticals first-quarter revenues down 61%

10 May 2010
Repros Therapeutics net loss decreases to $1.1M for first-quarter 2010

Repros Therapeutics net loss decreases to $1.1M for first-quarter 2010

10 May 2010
Positive results from Cytori's Celution-based ADRC trial for treatment of no-option chronic heart disease patients

Positive results from Cytori's Celution-based ADRC trial for treatment of no-option chronic heart disease patients

10 May 2010
Zilver PTX Drug-Eluting Peripheral Stent safe and effective for treating SFA lesions

Zilver PTX Drug-Eluting Peripheral Stent safe and effective for treating SFA lesions

10 May 2010
Everolimus-eluting stents more effective than paclitaxel-eluting stents

Everolimus-eluting stents more effective than paclitaxel-eluting stents

10 May 2010
Novel imaging techniques improve post heart attack survival rates in mouse model

Novel imaging techniques improve post heart attack survival rates in mouse model

10 May 2010
Fibrinogen may reduce bleeding complications in cardiac surgery, says study

Fibrinogen may reduce bleeding complications in cardiac surgery, says study

10 May 2010
Researchers launch NIH-sponsored clinical trial for spinal deformity

Researchers launch NIH-sponsored clinical trial for spinal deformity

7 May 2010
Threshold Pharmaceuticals reports $6.0M net loss for first-quarter 2010

Threshold Pharmaceuticals reports $6.0M net loss for first-quarter 2010

7 May 2010
CardioMEMS completes $37.9M financing

CardioMEMS completes $37.9M financing

7 May 2010
Osiris Therapeutics reports net income of $2.4M for first-quarter 2010

Osiris Therapeutics reports net income of $2.4M for first-quarter 2010

7 May 2010
Cytori Therapeutics to initiate European medical device approval study for Celution System

Cytori Therapeutics to initiate European medical device approval study for Celution System

7 May 2010
Arena Pharmaceuticals reports lower net loss of $31.3 million in first-quarter 2010

Arena Pharmaceuticals reports lower net loss of $31.3 million in first-quarter 2010

7 May 2010
Halozyme Therapeutics first-quarter net loss decreases to $11.8 million

Halozyme Therapeutics first-quarter net loss decreases to $11.8 million

7 May 2010
BioSpecifics Technologies total revenues for first-quarter increase to $2.7M

BioSpecifics Technologies total revenues for first-quarter increase to $2.7M

7 May 2010

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback